CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
1. CVS reported Q4 sales of $97.71 billion, exceeding expectations. 2. Health Care Benefits segment lagged, impacting overall revenue growth. 3. Analysts project improved margins and revenue growth for 2025. 4. CostVantage gaining traction, indicating positive future performance. 5. CVS stock rose 5.77% after strong quarterly results.